These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 31216433)

  • 1. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
    Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
    J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
    Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
    Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
    Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
    Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
    Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
    J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
    Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
    J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
    Zhou M; Liu X; Wu Y; Xiang Q; Yu R
    J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
    Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
    Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway.
    Cai Y; Wang Y; Zhi F; Xing QC; Chen YZ
    Evid Based Complement Alternat Med; 2018; 2018():9407945. PubMed ID: 29670663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
    Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
    [No Abstract]   [Full Text] [Related]  

  • 11. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
    Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.
    Xu X; Niu L; Liu Y; Pang M; Lu W; Xia C; Zhu Y; Yang B; Wang Q
    J Ethnopharmacol; 2020 Nov; 262():113129. PubMed ID: 32730886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel formula Sang-Tong-Jian improves glycometabolism and ameliorates insulin resistance by activating PI3K/AKT pathway in type 2 diabetic KKAy mice.
    Kuai M; Li Y; Sun X; Ma Z; Lin C; Jing Y; Lu Y; Chen Q; Wu X; Kong X; Bian H
    Biomed Pharmacother; 2016 Dec; 84():1585-1594. PubMed ID: 27829545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
    Li X; Li X; Wang G; Xu Y; Wang Y; Hao R; Ma X
    Front Med; 2018 Dec; 12(6):688-696. PubMed ID: 30421394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Based on network pharmacology to explore the effect and mechanism of Yipibushen decoction in improving obese type 2 diabetes mellitus with oligoasthenotspermia.
    Li G; Wang Q; Chen X; Yu P; Peng Q; Chen H; Ren S; Wang C; Su Y; Liang X; Sun M; Du X; He R
    J Ethnopharmacol; 2023 Dec; 317():116738. PubMed ID: 37369336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
    Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
    Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
    Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
    J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
    Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM.
    Chen D; Chen X; He C; Xiao C; Chen Z; Chen Q; Chen J; Bo H
    J Ethnopharmacol; 2023 Apr; 306():116162. PubMed ID: 36646159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice.
    Yu N; Fang X; Zhao D; Mu Q; Zuo J; Ma Y; Zhang Y; Mo F; Zhang D; Jiang G; Wu R; Gao S
    PLoS One; 2017; 12(1):e0168980. PubMed ID: 28045971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.